We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PSIG:NASDAQPS International Group Ltd. Analysis

Data as of 2026-06-13 - not real-time

$10.30

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

PS International Group Ltd. (PSIG) is trading at $10.30, comfortably above its 20‑day SMA of 8.56 and 50‑day SMA of 7.36, confirming a bullish technical backdrop. However, the RSI of 88 signals that the stock is deep in overbought territory, and the price sits just below the identified resistance level of $10.44, suggesting limited upside in the near term. Momentum indicators remain supportive, with a bullish MACD histogram and a positive MACD line above its signal, yet the extreme greed sentiment (Fear & Greed Index 89.86) adds a cautionary note. The company’s fundamentals are weak: trailing EPS is –$3.81, profit margin is –28.6%, and book value per share is negative, while free cash flow is surprisingly positive at $15.36 M. The DCF-derived fair value of $13.81 indicates the market may be undervaluing the stock relative to its intrinsic estimate, but the high 30‑day volatility of 49% and modest beta of 0.53 underscore considerable price swings. Cash on hand ($13.9 M) exceeds debt ($4.8 M), providing a solid liquidity cushion despite operating cash flow deficits. Overall, the stock sits at the intersection of strong technical momentum and fragile fundamentals, making short‑term moves risky while longer‑term valuation appears attractive if the company can reverse its earnings trend.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term moving averages confirming bullish trend
  • RSI in overbought zone indicating potential short‑term pullback
  • Proximity to resistance level limiting immediate upside

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • DCF fair value exceeds current price suggesting upside potential
  • Negative earnings and margins raise concerns about profitability
  • Strong cash position offsets operating cash‑flow deficits

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Fundamental weaknesses (negative EPS, book value) require turnaround
  • Undervalued relative to intrinsic estimate if earnings improve
  • High volatility and overbought technicals increase risk of large swings

Key Metrics & Analysis

Financial Health

Revenue Growth-37.30%
Profit Margin-28.63%
ROE-425.34%
ROA-3.23%
P/B Ratio-23.6
Op. Cash Flow$-1308650
Free Cash Flow$15.4M
Industry P/E30.6

Technical Analysis

TrendBullish
RSI87.8
Support$7.18
Resistance$10.44
MA 20$8.56
MA 50$7.36
MA 200$5.25
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$13.81
GradeUndervalued
TypeValue

Risk Assessment

Beta0.53
Volatility49.03%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.